Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • MarkiMark
    Junior Member
    • May 2019
    • 2

    #1

    Human Fibroblasts

    Hi all,

    Wanted to ask for suggestions-comments-opinions regarding this experiment;

    We are planning to sequence total RNA from 30 samples of human fibroblasts (literature points out that this type of cells are quite noisy).
    We are looking for DE genes, splicing variants and even novel isoforms.

    For that, total RNA will be extracted using the mirNeasy kit and then divided to two sequencing assays;

    1. Transcriptome sequencing, library construction by Illumina TruSeq stranded Total RNA library (RiboZero Gold rRNA removal). Run: NovaSeq 2X150bp, 60M reads per sample (=30M paired read per sample)

    2. smRNA sequencing, library construction using Illumina TruSeq small RNA library construction. Run : Hiseq 2500 rapid run mode, 1X50bp, 125M reads per lane (10-12 samples per lane).

    There will be no biological replicates due to passage limitations.
    After a few considerations, we have decided not to sequence technical repeats.
    We are aware that 60M reads per sample may not be sufficient for novel isoforms, but budget limitations exist.

    Many Thanks,

    Mark
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    How many groups in the experiment? How many samples per group? Are they paired samples (i.e. pre and post treatment?) What's the actual experimental setup? What question are you trying to answer? Where your samples RNA extracted on the same day? Libraries prepped on the same day? With the same reagents? What possible batch effects are there in your setup?

    Very hard to advise on anything other than to argue that biological replicates are important and technical replication largely unecessary.

    Comment

    • MarkiMark
      Junior Member
      • May 2019
      • 2

      #3
      30-40 samples total.
      Two groups- patients and controls (paired by gender and age)
      Group sizes are ~50\50%
      To avoid batch effects, cell samples were randomized to sets (in accordance to extraction groups) and matched samples were kept in the same set.
      The same for growth conditions

      We want to examine differences in gene expression (and regulation) between these two groups.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Working...